Purpose built for real clinical decisions.
Each module addresses a specific clinical situation where relevant information can support clinical assessment and decision-making.
Healthcare Providers / AI Modules
tcc AI Modules are medical device software designed to provide clinical decision support. They help healthcare professionals identify patients who may warrant further clinical attention and support more informed clinical decision-making.
From AI-generated risk prediction to score-based assessment, each module supports clinical decision-making as part of a comprehensive patient care strategy. Built on real-world healthcare data. Evidence-based. CE-marked Class IIa medical device software under the EU Medical Device Regulation (MDR).
Each module addresses a specific clinical situation where relevant information can support clinical assessment and decision-making.
tcc AI Modules can be deployed within tcc Core or integrated into existing healthcare systems and digital health solutions. For technology partners, selected capabilities can also be integrated into partner products and solutions through defined OEM and collaboration models.
tcc and Netcare have collaborated for several years in the development and evaluation of medical device software and AI-based clinical decision support solutions. The collaboration provides valuable real-world experience in applying digital healthcare technologies within complex healthcare environments.
The partnership is now entering its next stage, with Netcare taking on a distribution role for selected tcc products in South Africa.
No. tcc AI Modules are medical device software designed to provide clinical decision support. Clinical responsibility and final treatment decisions remain with qualified healthcare professionals.
Yes. The currently available modules are CE-marked Class IIa medical device software under the EU Medical Device Regulation (MDR).
Yes. tcc AI Modules can be deployed within tcc Core or integrated into existing healthcare systems and digital health solutions. For technology partners, selected capabilities can also be integrated into partner products and solutions through defined OEM and collaboration models, subject to the applicable regulatory framework.
The currently available portfolio includes the AI-generated Acute Kidney Injury (AKI) Prediction Service and Sepsis Prediction Service, as well as the score-based Early Deterioration Service.
The AI-generated prediction services are developed using real-world healthcare data within a medical device development and quality management framework.
Patient safety is addressed throughout the medical device lifecycle through risk management, verification and validation, quality controls and post-market activities. The AI Modules are designed to support – not replace – clinical judgment.
The AI Modules provide decision support through probability estimates and risk scores, supporting HCPs in assessing relevant clinical information, prioritizing clinical attention and making informed clinical decisions.